United Therapeutics Corp (NASDAQ:UTHR)
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
Promising pipeline
Recs
I believe United Therapeuti will bring in 89.99 points considering a 15% S&P performance. My target is $ 11.2.
Recs
Well-known futurist Ray Kurzweil is on the board of United Therapeutics. This should help the company outperform its peers over the long haul.
Recs
Franchise Player.
Recs
This is a small/mid cap high growth stock that should outperform the S&P during the bull market.
Recs
Will become the dominant player in the PAH market, strong pipeline in multiple high-profit potential orphan diseases like PAH, ILD, PF, Cancer, Stem Cell, and Virology. 30% annual growth over the last 5+ years.
Recs
low PEG, strong price uptrend
Recs
Recs
http://seekingalpha.com/article/133869-fda-clinical-trial-updates-watson-pharma-united-therapeutics-auxilium-dendreon?source=feed
Recs
This company is limited with products..... and competition for any existing product(s) will happen soon. Its medical device company (Medicomp) is really a small marginally profitable-if at all -firm run by a youngster who was given the job AND isn't a real board certified/practicing MD.
UTHR stock owners should better prepare to SELL now before and when the stock gets to the mid 40's.
Recs
Pipeline looks good.
Recs
UTHR is a terrific growth stock; accellerating earnings -- 80% in 08 and 68% in 09; recently reported fantastic earnings above street estimates.
Recs
UT leads the market in pulmonary hypertension with rapid growth and a better product than all the competitors.
Recs
VALUE LINES - TIMELY STOCKS IN TIMELY INDUSTRIES
Recs
Amazing leadership- many great suprises found in each annual report (no debt, diversity of pipeline, etc.)
Recs
Best biomed
Recs
Recs
NICE GROWTH EST, POSITIVE CASH, WILL BE A NICE STOCK FOR THE FUTURE EVEN IF THERE IS A BEAR MARKET COMING UP.
Recs
To be honest, this is a "gut feeling" pick, i feel that their is potential here to get back up to their 52 week high level.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 21 : 1 2 Next »